Project Search

sector_ico_Health_trans Human Health

Anti-Influenza Therapeutics – Development of M2 Inhibitors

  • Project Leaders: Michel Roberge
  • Institutions: University of British Columbia (UBC)
  • Budget: $272621
  • Program/Competition: Other Programs
  • Genome Centre(s): Genome British Columbia
  • Fiscal Year: 2014
  • Status: Closed

The key interim milestone (analog with improved activity/PK) was not achieved. CDRD has decided to discontinue the project and not proceed with remaining tasks in the plan. The project has ended. Based on the actual spending to September 30, 2014 and the discontinued activities, there will be no invoicing for the second tranche of funding (40%).